Antioxidant effects of combined vitamins C and E in acute myocardial infarction. The randomized, double-blind, placebo controlled, multicenter pilot myocardial infarction and VITamins (MIVIT) trial;Wpływ witamin antyoksydacyjnych C+E na przebieg kliniczny ostrego zawału serca. Pilotowe, randomizowane, wieloośrodkowe, podwójnie ślepe, kontrolowane placebo badanie MIVIT

Kardiologia Polska

Volumn 62, Issue 4, 2005, Pages 344-350

  Jaxa Chamiec, Tomasz ^a   Bednarz, Bronisław ^a   Drozdowska, Dorota ^b,i   Gessek, Jacek ^c,j   Gniot, Jacek ^d,k   Janik, Krzysztof ^e,l   Kawka Urbanek, Teresa ^f,m   Maciejewski, Paweł ^a   Ogórek, Michał ^g,n   Szpajer, Michał ^h,o  

^a GROCHOWSKI HOSPITAL   (Poland)

^b Municipal Hospital   (Switzerland)

^c M Kopernik Municipal Hospital   (Poland)

^d Municipal Hospital   (Poland)

^e T Chaubinski Municipal Hospital   (Poland)

^f Voivodship Hospital   (Poland)

^g Municipal Hospital   (Poland)

^h Department of Surgical Oncology   (Poland)

ⁱ Szpital Miejski   (Switzerland)

^j Szpital Miejski   (Poland)

^k Szpital Miejski   (Poland)

^l Szpital Miejski im T Chaubinskiego   (Poland)

^m Szpital Wojewódzki   (Poland)

ⁿ Piotrków Trybunalski   (Poland)

^o Szpital Morski im PCK   (Poland)

more..

Author keywords

Antioxidant vitamins; Free radicals; Myocardial infarction; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; PLACEBO; REACTIVE OXYGEN METABOLITE; STATINE DERIVATIVE; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ASYSTOLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LUNG EDEMA; MALE; MORTALITY; MULTICENTER STUDY; OXIDATIVE STRESS; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SHOCK; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VITAMIN SUPPLEMENTATION;

EID: 18144415000     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kloner R.A., Jennings R.B.: Consequences of brief ischemia: stunning, preconditioning, and their clinical implications. Circulation 2001, 104, 2981-2989.
2. Lefer D.J., Granger D.N.: Oxidative stress and cardiac disease. Am. J. Med. 2000, 109, 315-323.
3. Kaul N., Devaraj S., Jialal I.: Alpha-tocopherol and atherosclerosis. Exp. Biol. Med. 2001, 226, 5-12.
4. Padayatty S.J., Katz A., Wang Y. et al.: Vitamin C as an antioxidant: evaluation of its role in disease prevention. J. Am. Coll. Nutr. 2003, 22, 18-35.
5. Herbaczynska-Cedro K., Wartanowicz B., Panczenko-Kresowska B. et al.: Inhibitory effect of vitamin C and E on the oxygen free radical production in human polymorphonuclear leukocytes. Eur. J. Clin. Invest. 1994, 24, 316-319.
6. Herbaczynska-Cedro K., Klosiewicz-Wa̧sek B., Cedro K. et al.: Supplementation with vitamins C and E suppresses leukocyte oxygen free radical production in patients with myocardial infarction. Eur. Heart J. 1995, 16, 1044-1049.
7. Chamiec T., Herbaczynska-Cedro K., Ceremużyński L.: Effects of antioxidant vitamins C and E on signal-averaged electrocardiogram in acute myocardial infarction. Am. J. Cardiol. 1996, 77, 237-241.
8. Klein H.H., Pich S., Lindert S. et al.: Combined treatment with vitamins E and C in experimental myocardial infarction in pigs. Am. Heart J. 1989, 118, 667-673.
9. Axford-Gatley R.A., Wilson G.J.: Reduction of experimental myocardial infarct size by oral administration of alpha-tocopherol. Cardiovasc. Res. 1991, 25, 89-92.
10. Singh R.B., Niaz M.A., Rastogi S.S. et al.: Usefulness of antioxidant vitamins in suspected acute myocardial infarction (The Indian Experiment of Infarct Survival-3). Am. J. Cardiol. 1996, 77, 232-236.
11. Laskowski H., Minczykowski A., Wysocki H.: Mortality and clinical course of patients with acute myocardial infarction treated with streptokinase and antioxidants: manitol and ascorbic acid. Int. J. Cardiol. 1995, 48, 235-237.
12. Ross M.A.: Determination of ascorbic acid and uric acid in plasma by high-performance liquid chromatography. J. Chromatogr. B. Biomed. Appl. 1994, 657, 197-200.
13. Kaplan L.A., Miller J.A., Stein E.A. et al.: Simultaneous, high-performance liquid chromatographic analysis of retinol, tocopherols, lycopene and alpha- and beta-carotene in serum and plasma. Methods Enzymol. 1990, 189, 155-167.
14. Asplund K.: Antioxidant vitamins in the prevention of cardiovascular disease: a systemic review. J. Intern. Med. 2002, 251, 372-392.
15. Stephens N.G., Parsons A., Schofield P.M. et al.: Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996, 347, 781-786.
16. Fang J.C., Kinlay S., Beltrame J. et al.: Effect of vitamin C and E on regression of transplant-associated axteriosclerosis: a randomized trial. Lancet 2002, 359, 1108-1113.
17. Salonen R.M., Nyyssonen K., Kaikkonen J. et al.: Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression. The Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 2003, 107, 947-953.
18. The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N. Engl. J. Med. 2000, 342, 154-160.
19. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002, 360, 23-33.
20. Gokce N., Keaney J.F. Jr, Frei B. et al.: Long term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1999, 99, 3234-3240.
21. Motayama T., Kawano H., Kugiyama K. et al.: Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J. Am. Coll. Cardiol. 1998, 32, 1672-1679.
22. Huang A., Vita J.A., Venema R.C. et al.: Ascorbic acid enhances endothelial nitric oxide synthase activity by increasing intracellular tetrahydrobiopterin. J. Biol. Chem. 2000, 275, 17399-17406.
23. Chan A.C.: Partners in defense, vitamin E and vitamin C. Can. J. Physiol. Pharmacol. 1993, 71, 725-731.
24. Ikeda H., Koga Y., Oda T. et al.: Free oxygen radicals contribute to platelet aggregation and cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. J. Am. Coll. Cardiol. 1994, 24, 1749-1756.
25. Freedman J.E., Farhat J.H., Loscalzo J. et al.: Alpha-tocpherol inhibits aggregation of human platelets by a protein kinase C - dependent mechanism. Circulation. 1996, 94, 2434-2440.
26. Rota S., McWilliam N.A., Baglin T.P. et al.: Atherogenic lipoproteins support assembly of the prothrombinase complex and thrombin generation: modulation by oxidation and vitamin E. Blood. 1998, 91, 508-515.
27. Mehta J.L., Nichols W. W., Saldeen T.G. et al.: Superoxide dismutase decreases reperfusion arrhythmias and preserves myocardial function during thrombolysis with tissue plasminogen activator. J. Cardiovasc. Pharmacol. 1990, 16, 112-120.
28. Hamilton I.M., Gilmore W.S., Benzie I.F. et al.: Interaction between vitamins C and E in human subjects. Br. J. Nutr. 2000, 84, 261-267.
29. Sherman D.L., Keaney J.F., Biegelsen E.S. et al.: Pharmacological concentrations of ascorbic acid are required for beneficial effect on endothelial vasomotor function in hypertension. Hypertension 2000, 35, 936-941.
30. Kinlay S.K., Behrendt D., Fang J.C. et al.: Long-term effect of combined E and C on coronary and peripheral endothelial function. J. Am. Coll. Cardiol. 2004, 43, 629-634.